drugset / Trial / NCT02232178
Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant
RandomizedParallel-groupQuadruple-blindOther
Summary
Assess the pharmacokinetic profile of 2 doses of the XaraColl® implant after open laparotomy hernioplasty and assess the relative bioavailability of Xaracoll compared to a local bupivacaine infiltration.
Timeline
- Start
- 2014-10-20
- Primary completion
- 2015-02-23
- Completion
- 2015-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 150 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 200 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 300 mg | Other |
Indications
No indication recorded.